When we first met with Dr. Rudy Tanzi to discuss Cure Alzheimer's Fund, we asked him two things:
Can you recruit a group of first-class Alzheimer’s researchers to guide us in our investment in basic research into the causes of the disease?
What is the most important first step we can take to truly make a difference?
Dr. Tanzi answered the first question by assembling the group of researchers known as the Cure Alzheimer’s Fund Research Consortium. They answered the second question thusly: find all the genes that contribute to risk for Alzheimer’s disease.
Dr. Tanzi estimated that task would take about three years and about $3 million. He was right.
With the holidays approaching and the conclusion of 3 years of progress at Cure Alzheimer’s Fund, we are grateful for your support and excited about the challenges ahead.
The Progress. We are funding 17 research projects in 8 different outstanding research institutions across the nation.
First, a hearty thank you to all of you who have supported us. Your money has been put to good use. The first operating year of Cure Alzheimer’s Fund has been most gratifying for the founders, donors, researchers --- all of us committed to doing what we can to end the scourge of Alzheimer’s disease in our lifetime.
Founding Board Member
A Founding Board member of Cure Alzheimer’s Fund, Phyllis chairs the board of the Jerome Lyle Rappaport Charitable Foundation, and is a director of New Boston Fund, Inc., a real estate investment company with $1.5 billion assets under management. Her diverse management career includes senior positions at a Fortune 50 technology company, and she has an extensive background in public and non-profit service. She serves on college, hospital, museum, and public policy boards in Boston and Cambridge.
Henry McCance, Founding Board Member
Henry McCance is a Founding Board member of Cure Alzheimer’s Fund and Chairman of Greylock Partners, a leading venture capital firm with a distinguished and highly successful record of company building. His family situation brought him to this effort as his words describe here.
To capitalize on this rare “science moment” as Rudy (Tanzi) calls it, we are committed to focused, disciplined funding of targeted research which we refer to as the Venture approach. All of our Founders have strong business backgrounds, and two of us are long-time venture capitalists. We have all made careers from betting on people who rose to excellence and on providing the best resources available to help them achieve their potential. That is the approach we are bringing to Cure Alzheimer’s Fund.
Jeffrey Morby, Chairman, Cure Alzheimer's Fund
Welcome to the Cure Alzheimer's Fund website. This is an auspicious time for accelerating Alzheimer's disease research. More of us unfortunately are touched by this disease as friends, relatives and associates are afflicted. Additionally, as the "boomers" enter the most dangerous Alzheimer's age range (60+), we threaten to swamp our already fragile healthcare system.
Please join us Wednesday, September 16th, 2009 for a presentation at Boston’s Massachusetts General Hospital: The Alzheimer’s Genome Project: From Genes to Therapies by Dr. Rudy Tanzi.
Recorded on Wednesday May 20th, 2009, this hour-long webinar features Dr. Rudy Tanzi presenting breakthrough work in Alzheimer’s research and progress on the path to a cure. Dr. Tanzi spends about 30 minutes reviewing Alzheimer’s disease and describing some of his recent work, including the Alzheimer’s Genome Project. His presentation is followed by an additional 30 minutes of questions from participants.
Here is your chance.
Cure Alzheimer’s Fund is proud to be taking part in Massachusetts General Hospital’s America’s Cup Experience on June 24, 2008. Cure Alzheimer’s Fund co-Founder, Phyllis Rappaport, will be captaining one of the boats and would like to invite you to join her as a crew member! She will have the assistance of a professional crew so participants can do as little or as much as they want.
© 2005-2017 Cure Alzheimer's Fund. All rights reserved.